SER100 in Isolated Systolic Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

September 30, 2014

Conditions
Isolated Systolic Hypertension
Interventions
DRUG

SER100

DRUG

Placebo

Trial Locations (7)

2317

Medi3 Innlandet, Hamar

Unknown

FinnMedi Oy/Valkeakoski District Hospital, Tampere

CRST/Turku University Hospital, Turku

Semmelweiss University Hospital, Budapest

Brighton and Sussex University Hospital, Brighton

0450

Ulleval University Hospital, Oslo

HA1 3UJ

Northwick Park Hospital, Harrow

All Listed Sponsors
collaborator

Smerud Medical Research International AS

OTHER

collaborator

The Research Council of Norway

OTHER

lead

Serodus AS

INDUSTRY

NCT01987284 - SER100 in Isolated Systolic Hypertension | Biotech Hunter | Biotech Hunter